MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Familial Parkinson’s disease in Ireland

D.A. Olszewska, A. McCarthy, B. Magennis, O. Ross, T. Lynch (Dublin, Ireland)

Meeting: 2016 International Congress

Abstract Number: 639

Keywords: Parkinsonism

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Genetics

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To study the phenotype and subtypes of familial Parkinson’s disease (PD) in Ireland, establish the genetic background in a cohort of Irish PD patients and to identify pedigrees without known PD genes mutations for identification of novel PD genes (linkage analysis and next generation sequencing-NGS).

Background: 10 % of PD patients have a PD family history. Familial studies have led to the identification of causative gene mutations at 7 chromosome loci in either autosomal dominant (SNCA, LRRK2, VPS 35), or recessive (Parkin, DJ1, PINK1, ATP13A2) fashion.

Methods: We expanded upon a 12-year familial PD study (Gosal D, Wiley J, McCarthy A) and identified a further 158 familial cases. 98 of the 158 patients were partially studied previously (McCarthy A, Ross O) including detailed genetic testing of the known PD genes. We identified 3 Parkin positive patients among the 98 patients. 85% of pedigrees have autosomal dominant inheritance pattern. 60 new probands have been recruited and we expanded the promising pedigrees in 6 of the original 98 families and 16 of the 60 new families using a family study method.

Results: In 98 genetically-tested families we failed to find any LRRK2 mutations. We are doing genetic analysis of the 60 new probands at present. One kindred has 6 affected members with PD (3 were assessed). In analysis of the 60 new pedigrees male to female ratio was 1.6, mean age of PD onset was 55.2 (range 29-79). Young onset PD (<age 50) occurred in 26.6% (16/60). Mean disease duration from the symptom onset up to our assessment was 7.78 years (1-31). Average motor UPDRS was 21. 70% of patients had tremor-predominant disease, 26.6% had postural instability and gait disorder and 3.33% mixed disease. We identified 2 families with overlapping PD/ET. PD dementia (MOCA<21) occurred in 8.3%, cognitive impairment (MOCA <26) in additional 20% and hallucinations in 10%. Motor complications occurred in 48% of patients (wearing off in 23.5%, dyskinesia in 21.6%, freezing of gait in 18.3%, all 3 in 8.3%, wearing off with freezing episodes in 1.6%, wearing off and dyskinesia in 1.6%) and falls in 28.3%.

Conclusions: Familial PD is common. We identified 3 Parkin mutations but surprisingly we did not find any LRRK2 mutations among the 98 pedigrees. LRRK2 mutations frequency varies geographically and is uncommon in Ireland. We will perform NGS to identify new PD genes in the expanded pedigrees.

To cite this abstract in AMA style:

D.A. Olszewska, A. McCarthy, B. Magennis, O. Ross, T. Lynch. Familial Parkinson’s disease in Ireland [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/familial-parkinsons-disease-in-ireland/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/familial-parkinsons-disease-in-ireland/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley